TY - JOUR
T1 - Iron deficiency anemia-bridging the knowledge and practice gap
AU - Shander, Aryeh
AU - Goodnough, Lawrence T.
AU - Javidroozi, Mazyar
AU - Auerbach, Michael
AU - Carson, Jeffrey
AU - Ershler, William B.
AU - Ghiglione, Mary
AU - Glaspy, John
AU - Lew, Indu
N1 - Funding Information:
Aryeh Shander has been a consultant or speaker with honorarium for or received research support from Bayer, Luitpold, Masimo, Novartis, Novo Nordisk, OrthoBiotech, Pfizer, and Masimo & Zymogenetics. He is a founding member of SABM. Lawrence T. Goodnough has been a consultant for Eli Lilly, CSL Behring, Luitpold, AMAG, Amgen, and Centocorp/Biotech. Mazyar Javidroozi has been a consultant and contractor for SABM. Jeffrey Carson reported receiving grant support to his institution from Amgen as well as grants from the National Institutes of Health, personal fees from Cerus Corporation, and grants from Amgen. John Glaspy has received grant funding from Amgen, and he has been on Amgen's Speakers' Bureau. Other authors declare no relevant conflict of interests.
Funding Information:
Funding and support for this work was provided by the Society for the Advancement of Blood Management and AMAG Pharmaceuticals. The study sponsors had no role in study design, collection, analysis and interpretation of data, writing of the report, or the decision to submit the manuscript for publication.
PY - 2014/7
Y1 - 2014/7
N2 - Despite its high prevalence, anemia often does not receive proper clinical attention, and detection, evaluation, and management of iron deficiency anemia and iron-restricted erythropoiesis can possibly be an unmet medical need. A multidisciplinary panel of clinicians with expertise in anemia management convened and reviewed recent published data on prevalence, etiology, and health implications of anemia as well as current therapeutic options and available guidelines on management of anemia across various patient populations and made recommendations on the detection, diagnostic approach, and management of anemia. The available evidence confirms that the prevalence of anemia is high across all populations, especially in hospitalized patients. Anemia is associated with worse clinical outcomes including longer length of hospital stay, diminished quality of life, and increased risk of morbidity and mortality, and it is a modifiable risk factor of allogeneic blood transfusion with its own inherent risks. Iron deficiency is usually present in anemic patients. An algorithm for detection and management of anemia was discussed, which incorporated iron study (with primary emphasis on transferrin saturation), serum creatinine and glomerular filtration rate, and vitamin B12 and folic acid measurements. Management strategies included iron therapy (oral or intravenous), erythropoiesis-stimulating agents, and referral as needed.
AB - Despite its high prevalence, anemia often does not receive proper clinical attention, and detection, evaluation, and management of iron deficiency anemia and iron-restricted erythropoiesis can possibly be an unmet medical need. A multidisciplinary panel of clinicians with expertise in anemia management convened and reviewed recent published data on prevalence, etiology, and health implications of anemia as well as current therapeutic options and available guidelines on management of anemia across various patient populations and made recommendations on the detection, diagnostic approach, and management of anemia. The available evidence confirms that the prevalence of anemia is high across all populations, especially in hospitalized patients. Anemia is associated with worse clinical outcomes including longer length of hospital stay, diminished quality of life, and increased risk of morbidity and mortality, and it is a modifiable risk factor of allogeneic blood transfusion with its own inherent risks. Iron deficiency is usually present in anemic patients. An algorithm for detection and management of anemia was discussed, which incorporated iron study (with primary emphasis on transferrin saturation), serum creatinine and glomerular filtration rate, and vitamin B12 and folic acid measurements. Management strategies included iron therapy (oral or intravenous), erythropoiesis-stimulating agents, and referral as needed.
KW - Anemia
KW - Anemia, iron-deficiency
KW - Blood transfusion
KW - Hemoglobin
KW - Iron
UR - http://www.scopus.com/inward/record.url?scp=84903445081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903445081&partnerID=8YFLogxK
U2 - 10.1016/j.tmrv.2014.05.001
DO - 10.1016/j.tmrv.2014.05.001
M3 - Review article
C2 - 24931617
AN - SCOPUS:84903445081
SN - 0887-7963
VL - 28
SP - 156
EP - 166
JO - Transfusion Medicine Reviews
JF - Transfusion Medicine Reviews
IS - 3
ER -